www.tyratech.com
TyraTech Nature's Technology effectively controls insects and parasites while providing a new level of safety for people, animals and the environment. TyraTech's patented scientific process targets receptors active only in invertebrates, not in humans or animals. TyraTech leverages this scientific platform to develop natural products that are as effective as traditional chemical options.
TyraTech wins latest round in Molecular Securities case
Natural pesticides business TyraTech (LON:TYR) announced this morning that it has won the latest round in a legal case the firm is involved in with Molecular Securities Incorporated.
TyraTech said that the State of New York Court of Appeals issued a decision on Octover 20 that denies Molecular’s request to appeal the May 26 2011 ruling by the New York Supreme Court in favour of TyraTech and against Molecular. This decision dismissed Molecular’s complaint in its entirety.
In November 2008, Molecular filed a complaint against TyraTech asserting claims for breach of contract and quantum merit. Molecular claimed it was owed US$2,760,470 for services it said it provided to TyraTech, as well as interest, lawyers’ fees and costs.
TyraTech said that it believes the Court of Appeals ruling will bring to an end any further litigation against the firm.
Yesterday, TyraTech announced that it had engaged Destum Partners, a US-based biopharmaceutical consultancy to assist it in seeking suitable partners for TyraTech’s natural head lice product. TyraTech’s head lice product uses its ‘Nature’s Technology’ approach and represents the firm’s first product entry in the personal health care market. The firm’s patented formulation uses combinations of natural plant oils.



















